When current approved treatments fail to satisfy patients’ needs, other treatment options including gaining access to investigational medicines through clinical trials may be available.

Clinical trials are human research studies designed to evaluate if an investigational medicine is safe and effective for patients. People who choose to participate in clinical trials play a vital role in developing new medicines, which may support approval by regulatory health authorities and make these medicines more broadly available to patients who may need them. For current development status of Antroquinonol (Hocena®), please check out our PIPELINE page. To learn more about the ongoing clinical trial, including your potential eligibility to participate, please consult with your doctor or visit ClinicalTrials.gov.

Study Title Indication
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized PatientsCoronavirus, Covid-19
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer Pancreatic Cancer
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC NSCLC
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects NSCLC
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients AML
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia Hyperlipidemia
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B HBV
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B HBV
A Trial of Antroquinonol in Patients With Atopic Dermatitis Atoptic Dematitis
A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis Atoptic Dematitis